Inventor · disambiguated record
John Grange
Also filed as: GRANGE JOHN · GRANGE JOHN A
18 granted patents·3 pending applications·617 citations·filing 1987–2024
95Inventor score
Top patents by PatentIndex Score
21 records- 0195US5491302AMicroelectronic bonding with lead motionTESSERA INC·Filed 1994·Granted Feb 13, 1996·159 cites·36 claims
- 0294US5398863AShaped lead structure and methodTESSERA INC·Filed 1993·Granted Mar 21, 1995·171 cites·13 claims
- 0393US11318193B2Immunogenic treatment of cancerIMMODULON THERAPEUTICS LTD·Filed 2018·Granted May 3, 2022·9 cites·12 claims
- 0492US5390844ASemiconductor inner lead bonding toolTESSERA INC·Filed 1993·Granted Feb 21, 1995·144 cites·19 claims
- 0591US11554166B2Immunogenic treatment of cancerIMMODULON THERAPEUTICS LTD·Filed 2020·Granted Jan 17, 2023·3 cites·14 claims
- 0690US10610578B2Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapyIMMODULON THERAPEUTICS LTD·Filed 2018·Granted Apr 7, 2020·7 cites·16 claims
- 0787US10610577B2Checkpoint inhibitor and a whole cell Mycobacterium for use in cancer therapyIMMODULON THERAPEUTICS LTD·Filed 2014·Granted Apr 7, 2020·7 cites·13 claims
- 0887US2025170231A1Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapyIMMODULON THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0985US8617520B2Cancer therapyAKLE CHARLES·Filed 2012·Granted Dec 31, 2013·9 cites·11 claims
- 1084US11000584B2Checkpoint inhibitor and a whole cell Mycobacterium for use in cancer therapyIMMODULON THERAPEUTICS LTD·Filed 2020·Granted May 11, 2021·1 cites·20 claims
- 1184US10994002B2Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapyIMMODULON THERAPEUTICS LTD·Filed 2020·Granted May 4, 2021·1 cites·20 claims
- 1284US10925952B2Checkpoint inhibitor and a whole cell Mycobacterium for use in cancer therapyIMMODULON THERAPEUTICS LTD·Filed 2020·Granted Feb 23, 2021·1 cites·20 claims
- 1382US4870830ACryogenic fluid delivery systemHYPRES INC·Filed 1987·Granted Oct 3, 1989·40 cites·21 claims
- 1477US2023149525A1Immunogenic treatment of cancerIMMODULON THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1575US12042532B2Checkpoint inhibitor and a whole cell Mycobacterium for use in cancer therapyIMMODULON THERAPEUTICS LTD·Filed 2021·Granted Jul 23, 2024·0 cites·17 claims
- 1674US10071124B2Treatment of post-traumatic stress disorder with isolated MycobacteriumIMMODULON THERAPEUTICS LTD·Filed 2013·Granted Sep 11, 2018·2 cites·12 claims
- 1772US5619017AMicroelectronic bonding with lead motionTESSERA INC·Filed 1995·Granted Apr 8, 1997·37 cites·4 claims
- 1855US2014356397A1Immunogenic Treatment Of CancerIMMODULON THERAPEUTICS LTD·Filed 2012·Application pending·0 cites
- 1946US6248656B1Metal-jacketed lead manufacturing process using resist layersTESSERA INC·Filed 1999·Granted Jun 19, 2001·13 cites·25 claims
- 2043US5072591AFlexible transfer line exhaust gas shieldHYPRES INC·Filed 1989·Granted Dec 17, 1991·10 cites·17 claims
- 2123US4869077AOpen-cycle cooling apparatusHYPRES INC·Filed 1987·Granted Sep 26, 1989·3 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →